Gastric Cancer, MetastaticPhase 1/2NCT07509008
TROP2 CAR/IL-15 TGFBR2 KO NK Cells
TROP2 CAR/IL-15 TGFBR2 KO NK Cells Delivered Intraperitoneally For The Management Of Gastric Cancer Metastatic To The Peritoneum
5 Phase 1 studies recruiting right now, most recently updated first.
Open the Phase 2 page · a list of only those studies
Triangle is made by Triangle Health, Inc.
Stomach and esophagus5 studies
Gastric Cancer, MetastaticPhase 1/2NCT07509008
TROP2 CAR/IL-15 TGFBR2 KO NK Cells Delivered Intraperitoneally For The Management Of Gastric Cancer Metastatic To The Peritoneum
HER2-Positive Advanced Gastro-Esophageal and GI CancersPhase 1NCT05274048
Neratinib and Fam-Trastuzumab Deruxtecan in Advanced Gastro-esophageal Cancer Patients
Advanced Esophageal, Gastric or GEJ CancerPhase 1/2NCT07818018
2141-V11 in People With Esophageal, Gastric, or Gastroesophageal Junction Adenocarcinoma
Gastric Cancer With Peritoneal MetastasesPhase 1NCT06675136
Nab-Paclitaxel PIPAC in Combination With Paclitaxel and Ramucirumab for the Treatment of Stomach Cancer With Peritoneal Metastases
Abdominopelvic MetastasesPhase 1NCT05880667Papers
Adaptive Radiation for Abdominopelvic Metastases